FDA Inspection
AstraZeneca Pharmaceuticals LPAstraZeneca Pharmaceuticals LP – FDA Inspection, Jan 27, 2017
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on January 27, 2017, issued by the Baltimore District Office, covering human drugs.
- People
- Diane L. Raccasi (Issuing Officer)
- Maria J. Lopez- Barragan (Issuing Officer)
- Zhong Li
View Company Profile
ID · a0a1d2cb-acc7-4166-bea1-b2603ebcba60
Inspection Facts
- Inspection number
- 1001245
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca Pharmaceuticals LP
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 7, 2024 | Not classified | Baltimore District Office | |
| January 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2019 | Not classified | Baltimore District Office | |
| August 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2017 | Not classified | Baltimore District Office |
Other documents for AstraZeneca Pharmaceuticals LP
- FDA Inspection 1242118 - 2024-06-07
- FDA Inspection 1197584 - 2023-01-19
- FDA Inspection 1103507 - 2019-08-26
- FDA Inspection 1062666 - 2018-08-17
- FDA Inspection 1025484 - 2017-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.